(Alliance News) - Sensyne Health PLC on Friday said is has made a diabetes monitoring system available to the UK's National Health Service free of charge in response to the Covid-19 pandemic.
The GDm-Health product monitors diabetes in pregnant women.
Chief Executive Officer Paul Drayson said: "In light of the UK government's guidelines around 'social distancing' to combat the ongoing Covid-19 pandemic, there is now a greater focus than ever before on the use of remote patient monitoring to reduce the burden on limited NHS resources and help high-risk people stay at home.
"Providing this product free of charge during the pandemic will enable the NHS to adopt GDm-Health quickly and provide remote care for more pregnant women during this crucial time and hence reduce hospital visits for this high-risk group."
Shares in the company closed 8.4% higher at 45.00 pence each in London on Friday.
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
